- John Zarocostas
- 1Geneva
A World Health Organization’s expert panel on vaccine safety has called for more investigations after examining new evidence that indicates children and adolescents faced an increased risk of narcolepsy after being vaccinated against H1N1 influenza with Pandemrix manufactured by GlaxoSmithKline.
The recommendation from WHO’s independent Global Advisory Committee on Vaccine Safety was made after reviewing data from at least 12 countries where Pandemrix has been used, including …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking